Edesa Biotech (EDSA) Inventory (2014 - 2019)
Edesa Biotech (EDSA) posted Inventory of $77913.0 for Q2 2019, down 68.06% sequentially from $243972.0 in Q1 2019, and down 67.19% YoY from $237494.0 in Q2 2018.
Edesa Biotech (EDSA) Inventory (2014 - 2019) Analysis & Trends
Edesa Biotech has reported Inventory for 6 years, with the latest figure at $77913.0 in Q2 2019.
- Quarterly Inventory fell 67.19% year-over-year to $77913.0 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $77913.0 (down 67.19% YoY) and the FY2018 annual result came in at $224267.0, up 229.25% from the prior year.
- Inventory eased to $77913.0 in Q2 2019 per EDSA's latest filing, from $243972.0 in the prior quarter.
- Over five years, Inventory peaked at $568698.0 in Q2 2016 and troughed at $68114.0 in Q3 2017.
- A 5-year average of $278418.5 and a median of $237494.0 in 2018 frame the typical range for Inventory.
- The sharpest annual moves came in 2016 and 2017: Inventory surged 302.12% in 2016, then slumped 75.22% in 2017.
- Over 5 years, Inventory stood at $527958.0 in 2015, then plunged by 37.57% to $329583.0 in 2016, then tumbled by 64.03% to $118540.0 in 2017, then jumped by 89.19% to $224267.0 in 2018, then slumped by 65.26% to $77913.0 in 2019.
- According to Business Quant data, Inventory over the past three periods registered $77913.0, $243972.0, and $224267.0 for Q2 2019, Q1 2019, and Q3 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 97.11 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 142.38 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 128.86 Mn |
| 10 | Edesa Biotech | 43.15 Mn | 43.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 77,913.00 |
| Mar 31, 2019 | 243,972.00 |
| Sep 30, 2018 | 224,267.00 |
| Jun 30, 2018 | 237,494.00 |
| Mar 31, 2018 | 205,364.00 |
| Dec 31, 2017 | 118,540.00 |
| Sep 30, 2017 | 68,114.00 |
| Jun 30, 2017 | 140,947.00 |
| Mar 31, 2017 | 310,574.00 |
| Dec 31, 2016 | 329,583.00 |
| Sep 30, 2016 | 249,430.00 |
| Jun 30, 2016 | 568,698.00 |
| Mar 31, 2016 | 543,463.00 |
| Dec 31, 2015 | 527,958.00 |
| Sep 30, 2015 | 557,280.00 |
| Jun 30, 2015 | 194,367.00 |
| Mar 31, 2015 | 135,151.00 |
| Dec 31, 2014 | 134,308.00 |